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Deletion of pLcγ1 in GABAergic 
neurons increases seizure 
susceptibility in aged mice
Hye Yun Kim1, Yong Ryoul Yang2, Hongik Hwang3, Ha-Eun Lee1, Hyun-Jun Jang1, Jeongyeon Kim4, 
Esther Yang5, Hyun Kim5, Hyewhon Rhim3, Pann-Ghill Suh1,4* & Jae-Ick Kim  1*
Synaptic inhibition plays a fundamental role in the information processing of neural circuits. It sculpts 
excitatory signals and prevents hyperexcitability of neurons. Owing to these essential functions, 
dysregulated synaptic inhibition causes a plethora of neurological disorders, including epilepsy, autism, 
and schizophrenia. Among these disorders, epilepsy is associated with abnormal hyperexcitability of 
neurons caused by the deficits of GABAergic neuron or decreased GABAergic inhibition at synapses. 
Although many antiepileptic drugs are intended to improve GABA-mediated inhibition, the molecular 
mechanisms of synaptic inhibition regulated by GABAergic neurons are not fully understood. Increasing 
evidence indicates that phospholipase Cγ1 (PLCγ1) is involved in the generation of seizure, while the 
causal relationship between PLCγ1 and seizure has not been firmly established yet. Here, we show 
that genetic deletion of PLCγ1 in GABAergic neurons leads to handling-induced seizure in aged mice. 
In addition, aged Plcg1F/F; Dlx5/6-Cre mice exhibit other behavioral alterations, including hypoactivity, 
reduced anxiety, and fear memory deficit. Notably, inhibitory synaptic transmission as well as the 
number of inhibitory synapses are decreased in the subregions of hippocampus. These findings 
suggest that PLCγ1 may be a key determinant of maintaining both inhibitory synapses and synaptic 
transmission, potentially contributing to the regulation of E/I balance in the hippocampus.
GABAergic neurons synthesize and release the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that 
controls the excitation of neurons in the brain. Although GABAergic inhibitory neurons constitute just 10–25% 
of the total number of cortical and hippocampal neurons, synaptic inhibition exerted by these neurons plays an 
essential role in regulating the synaptic transmission, synaptic plasticity, firing activity, and the synchronization of 
neurons through maintaining the appropriate excitation and inhibition balance (E/I balance)1. Recently, multiple 
lines of evidence have shown that the dysfunction of GABAergic neurons is implicated in various brain disorders, 
including epilepsy, autism, and schizophrenia. The alterations of population, structure, and synaptic connec-
tion in GABAergic neurons were observed in the patients and animal models of brain disorders, indicating that 
GABAergic inhibition is vital for the maintenance of normal functions in neural circuits2–4.
Epilepsy, one of the neurological disorders related to the dysfunction of GABAergic neurons, is characterized 
by recurrent seizures that are caused by abnormal hyperexcitation and the synchronization of neuronal activity. 
Approximately 60 million people worldwide suffer from epilepsy. Importantly, age-related prevalence of epilepsy 
in elderly people is higher than young people5. Unlike childhood epilepsy mostly caused by genetic mutations 
and developmental defects, the epilepsy in elderly people is considered to stem from the more complex interplay 
between genetic and environmental factors. In most cases, however, the detailed molecular and cellular mecha-
nisms of epileptogenesis remain still unclear.
Brain-derived neurotrophic factor (BDNF) is a protein having multi-faceted roles in orchestrating develop-
ment, synapse formation, and cognitive functions such as learning and memory in the brain. BDNF and its recep-
tor TrkB (tyrosine receptor kinase B) signaling is one of the most likely candidates that are believed to contribute 
to the etiology of epileptogenesis. BDNF level and the phosphorylation of TrkB are upregulated in human patients 
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as well as animal models of epileptic seizures6–9. Phospholipase C γ1 (PLCγ1) is a downstream enzyme activated 
by TrkB. Once activated, it hydrolyzes a phosphatidylinositol 4,5-bisphosphate (PIP2), generating diacylglycerol 
(DAG) and inositol 1,4,5-trisphosphate (IP3). These second messengers regulate diverse neuronal functions in 
the brain through the activation of protein kinase C (PKC) and intracellular calcium release10,11. In adult brain, 
PLCγ1 is highly expressed in cortex and hippocampus. More importantly, TrkB activation is accompanied by 
the elevated phosphorylation of PLCγ1 in the animal model of epilepsy12. Furthermore, neuron-specific TrkB 
conditional knockout mice show reduced seizure susceptibility in kindling epilepsy model and the disrupted 
interaction between TrkB and PLCγ1 prevents the generation of seizure12–14. Despite these findings, there remains 
a good deal of uncertainty about the specific role of PLCγ1 in the etiology of epileptogenesis.
Here, we investigate the cell-type specific role of PLCγ1 in the brain by targeting GABAergic neurons. 
GABAergic neuron-specific PLCγ1 conditional knockout mice, Plcg1F/F; Dlx5/6-Cre, exhibit the handling-induced 
recurrent seizures and epileptic EEG patterns when they are at least 6 months old. This occurrence of seizure is 
accompanied by other behavioral alterations including hypoactivity, reduced anxiety, and impaired fear mem-
ory. Although the number of GABAergic neurons is marginally affected, the expression of GABAergic synaptic 
markers and the number of inhibitory synaptic puncta are noticeably reduced in the hippocampal subregions of 
aged Plcg1F/F; Dlx5/6-Cre mice, which results in the attenuation of inhibitory synaptic transmission in CA3 area 
of the hippocampus. Taken together, our findings suggest that PLCγ1 may be one of principal molecular deter-
minants modulating hippocampal circuit by maintaining the proper level of synaptic inhibition via GABAergic 
interneurons.
Results
Aged PLCγ1 conditional knockout mice exhibit the handling-induced seizures. To determine 
the cell-type specific roles of PLCγ1 in the brain in vivo, we generated the GABAergic neuron-specific PLCγ1 
conditional knockout mice. We used Dlx5/6-Cre mice in which Cre recombinase driven by Dlx5/6 promoter is 
expressed in most of developing and mature GABAergic neurons (Fig. 1a). Dlx5 and Dlx6 (distal-less homeobox 5 
and 6 genes) are reported to be implicated in the development and migration process of GABAergic neurons15,16. 
These Dlx5/6-Cre mice were bred to Plcg1F/F mice to produce Plcg1F/F; Dlx5/6-Cre mice. We confirmed the dele-
tion of PLCγ1 in GABAergic neurons using western blotting and fluorescence in situ hybridization. Because the 
percentage of GABAergic neurons in the striatum is relatively much higher than the ones in the cortex and the 
hippocampus, the expression of PLCγ1 appeared significantly decreased only in the striatum compared with 
the cortex and the hippocampus (Fig. S1a,b). Fluorescence in situ hybridization data also validated the western 
blotting analysis, showing that the expression of PLCγ1 mRNA was reduced in the hippocampus of Plcg1F/F; 
Dlx5/6-Cre mice (Fig. S1c).
We first examined the behavioral consequences of cell-type specific deletion of PLCγ1 in the brain. Most 
notably, Plcg1F/F; Dlx5/6-Cre mice began to show recurrent behavioral seizures by routine handling stimulus when 
the mice reached 6 months old (Fig. 1b). 75% of aged Plcg1F/F; Dlx5/6-Cre mice exhibited seizure behaviors and 
the incidence of seizures was increased with age (Fig. 1c,d). Unexpectedly, handling-induced seizure was also 
observed from a small percentage of control mice when they were at around 10–11 months of age (Fig. 1c,d). 
Representative symptoms of seizure in aged Plcg1F/F; Dlx5/6-Cre mice are head nodding, and stiff body. In severe 
cases, losing posture, clonus of the forelimbs, and jumping were also found in Plcg1F/F; Dlx5/6-Cre mice, whereas 
none of these symptoms were detected in control mice (Supplementary Video 1). Using Racine scale17, we scored 
behavioral seizure grade: grade (1) stiffness and rigid posture; (2) head nodding; (3) partial forelimb clonus; (4) 
continuous severe whole body seizures; (5) falling, forelimb clonus and jumping (generalized motor convulsions). 
About 66.7% of Plcg1F/F; Dlx5/6-Cre mice exhibited mild seizures, 25% of them showed grade 2 seizures, and 
severe seizures were monitored in 8.3% of Plcg1F/F; Dlx5/6-Cre mice (Fig. 1e). There was, however, no significant 
difference in survival (or mortality) rate between control and Plcg1F/F; Dlx5/6-Cre mice (data not shown). It is 
important to note that seizure susceptibility induced in young adult (8–12 weeks old) mice by pilocarpine was 
comparable between control and Plcg1F/F; Dlx5/6-Cre mice, whereas excitatory neuron-specific PLCγ1 knockout 
mice (Plcg1F/F; CaMKIIα-Cre mice) displayed attenuated pilocarpine-induced seizure (Fig. S2a). These results 
potentially indicate that PLCγ1 may play differential roles for the generation of seizure in a cell-type-specific 
manner.
To interrogate other behavioral alterations induced by GABAergic neuron-specific deletion of PLCγ1, we 
conducted behavioral test batteries. In open field test, aged (10–16 months old) Plcg1F/F; Dlx5/6-Cre mice showed 
hypoactivity in locomotion and the total distance travelled was remarkably diminished (Fig. 1f–h). Moving 
duration in open field was also significantly reduced in Plcg1F/F; Dlx5/6-Cre mice (Fig. 1i). Interestingly, Plcg1F/F; 
Dlx5/6-Cre mice spent less time only in exploring the peripheral zone of the open field, possibly indicating the 
decreased level of anxiety (Fig. 1j). To further assess the anxiety level, we carried out the elevated plus maze 
(Fig. 1k). In elevated plus maze, Plcg1F/F; Dlx5/6-Cre mice spent more time in the open arms than control mice, 
while Plcg1F/F; Dlx5/6-Cre mice spent less time in the closed arms than control mice (Fig. 1l,m). This altered 
anxiety was also replicated in the entry number to each arm (Fig. 1n,o). These behavioral phenotypes are clearly 
indicative of low anxiety in Plcg1F/F; Dlx5/6-Cre mice. We also checked locomotive and anxiety behaviors in young 
adult (8–12 weeks old) mice. In young age, locomotion was slightly attenuated in Plcg1F/F; Dlx5/6-Cre mice and 
total moving time in open field was only statistically different between the genotypes (Fig. S2b–d). Meanwhile, 
the reduction of exploration in the peripheral zone of open field was detected again in young Plcg1F/F; Dlx5/6-Cre 
mice (Fig. S2e). Consistent with this result, young Plcg1F/F; Dlx5/6-Cre mice began to exhibit decreased anxiety in 
elevated plus maze (Fig. S2f–i).
Previous studies have implicated PLCγ1 with the regulation of epileptogenesis in the hippocampus. To 
examine the possible role of PLCγ1 in the hippocampus, we performed contextual fear conditioning, which is 
one form of the hippocampus-dependent learning. Contextual fear memory was markedly impaired 24 hours 
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Figure 1. Aged Plcg1F/F; Dlx5/6-Cre mice exhibit handling-induced seizures and behavioral aberrations. (a) 
Experimental design for the generation of Plcg1F/F; Dlx5/6-Cre mice. (b) Normal behavior in control mice and 
handling-induced seizures in Plcg1F/F; Dlx5/6-Cre mice. (c) Percentage of seizure occurrence by the genotypes 
(control, 2 of 13 mice; Plcg1F/F; Dlx5/6-Cre, 12 of 16 mice; Chi-square test, **P = 0.0014). (d) The number of 
mice at age of seizure onset. (e) Assessment of seizure grade in Plcg1F/F; Dlx5/6-Cre mice by Racine scale. (f) 
Representative tracing of open-field test for control (n = 9) and Plcg1F/F; Dlx5/6-Cre mice (n = 11). (g) Distance 
travelled with 10 min interval in the open-field test (two-way repeated measures ANOVA, genotype effect, 
*P = 0.0105). (h) Total distance travelled in the open-field chamber (unpaired t-test, **P = 0.0077). (i) Time spent 
moving in open-field chamber (unpaired t-test, **P = 0.0012). (j) Thigmotaxis in the open-field test (two-way 
repeated measures ANOVA, genotype effect, **P = 0.0077, **Pperiphery = 0.0046 in Sidak’s multiple comparison 
test). (k) Representative tracing of elevated plus maze for control (n = 12) and Plcg1F/F; Dlx5/6-Cre mice (n = 9). 
(l,m) Time spent in open (l) and closed arm (m) of elevated plus maze (unpaired t-test, ***Popen = 0.0002, 
***Pclosed = 0.0004). (n,o) Entry number in open (n) and closed arm (o) of elevated plus maze (unpaired t-test, 
**Popen = 0.0034, *Pclosed = 0.0158). (p) Experimental scheme for contextual fear conditioning and memory. (q) 
Contextual fear memory 24 hours after conditioning (control, n = 8; Plcg1F/F; Dlx5/6-Cre, n = 11; unpaired t-test, 
*P = 0.0433). (r) Percentage of spontaneous alteration for 10 min in the Y-maze test (control, n = 8; Plcg1F/F; 
Dlx5/6-Cre, n = 11; unpaired t-test, P = 0.4975). (s) Immobility time in the tail suspension test (control, n = 8; 
Plcg1F/F; Dlx5/6-Cre, n = 11; unpaired t-test, P = 0.8725). (t) Immobility time in the forced swim test (control, 
n = 8; Plcg1F/F; Dlx5/6-Cre, n = 11; unpaired t-test, P = 0.7039). All data were expressed as mean ± SEM.
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after conditioning in aged Plcg1F/F; Dlx5/6-Cre mice (Fig. 1p,q), while there was no difference between the gen-
otypes in working memory that was independent of hippocampal functions (Fig. 1r). Behavioral immobility, 
which is considered to reflect either behavioral despair or stress-coping strategy, was not affected by GABAergic 
neuron-specific deletion of PLCγ1 (Fig. 1s,t). Taken together, these data point to a possible role of PLCγ1 in 
modulating GABAergic neurons and its malfunction may cause seizures and other behavioral alterations that are 
either hippocampus-dependent or hippocampus-independent.
Epileptic EEG patterns are detected in aged Plcg1F/F; Dlx5/6-Cre mice. Electroencephalogram 
(EEG) is usually used to detect the characteristic patterns of epileptic seizures in both human patients and animal 
models. We next sought to determine whether GABAergic neuron-specific deletion of PLCγ1 contributes to the 
generation of epileptic EEG signals. To monitor EEG waveforms, we positioned EEG electrodes directly on the 
dura mater overlying the hippocampus from each hemisphere. After the recovery from electrode implantation, 
EEG recording was conducted for 7 days in freely moving mice (Fig. 2a). During the recording period, con-
trol mice displayed normal EEG signal, lacking any signs of epileptic EEG patterns (Fig. 2b). In aged Plcg1F/F; 
Dlx5/6-Cre mice, however, abnormal EEG patterns including high frequency waveforms were detected even when 
there was no behavioral seizure. Of note, these aberrant waveforms were also observed without handling stim-
ulus, suggesting that physical stimulus is not a prerequisite for the generation of epileptic EEG abnormalities in 
Plcg1F/F; Dlx5/6-Cre mice (Fig. 2c). With the manifestation of seizures, we could also observe typical seizure EEG 
in Plcg1F/F; Dlx5/6-Cre mice (Fig. 2d). Next, we conducted the power spectrum analysis of EEG waveforms to 
characterize the types of seizure. EEG signals were divided into several frequency bands via fast Fourier transfor-
mation (FFT): delta (0.5–4 Hz), theta (4–8 Hz), alpha (8–12 Hz), beta (12–30 Hz), gamma (30–100 Hz) frequency. 
These frequency bands have been known to be altered in various pathological conditions. Previous studies 
reported that high frequency EEG signal such as gamma oscillations are detected from both epilepsy patients 
and animal models18,19. Moreover, it was shown that gamma oscillation is regulated by GABAergic interneurons 
whose dysfunction could result in abnormal gamma oscillation patterns20. Akin to these findings, the analy-
sis of EEG power spectrum revealed that the power of gamma frequency band was highly increased in aged 
Plcg1F/F; Dlx5/6-Cre mice, while there was no difference between the genotypes in other frequency bands (Fig. 2e). 
Currently, it is still controversial whether the enhanced high-frequency wave in gamma range can directly cause 
epileptic seizures or is just one of various symptoms in epilepsy. This result indicates that the dysfunction of 
GABAergic neurons by lack of PLCγ1 could induce the epileptic EEG phenotypes in aged Plcg1F/F; Dlx5/6-Cre 
mice, likely through increased gamma oscillation.
The number of GABAergic synapses is markedly decreased in the hippocampus of aged Plcg1F/F; 
Dlx5/6-Cre mice. Altered expression of key molecules or loss of cell number in hippocampal GABAergic 
interneurons were observed in the animal models of epilepsy and human hippocampal epilepsy21,22. To search 
for the underlying circuit mechanisms behind the seizure and epileptic EEG patterns in aged Plcg1F/F; Dlx5/6-Cre 
mice, we investigated the possible changes of GABAergic interneurons in the hippocampus. First, we examined 
any gross structural abnormalities in the hippocampus of Plcg1F/F; Dlx5/6-Cre mice by NeuN immunostaining. 
There was no overall changes in the hippocampus between the genotypes (Fig. S3). Owing to the lack of available 
PLCγ1 antibody for immunohistochemistry, we used EYFP reporter mice (R26R-EYFP) by crossing with Plcg1F/F; 
Dlx5/6-Cre mice to track GABAergic neurons in which PLCγ1 was knock-outed. The loss of GABAergic interneu-
rons could be measured by counting the number of EYFP-positive neurons in each sub-region of hippocampus 
such as dentate gyrus (DG), CA3, and CA1. According to publicly-available single cell RNA sequencing data-
base (http://interneuron.mccarrolllab.org), Plcg1 is mainly expressed in parvalbumin (PV)- and somatostatin 
(SST)-positive interneurons, while vasoactive intestinal peptide (VIP) and other GABAergic interneuronal sub-
types exhibit relatively weak expression in the mouse brain. In the absence of PLCγ1, the number of GABAergic 
interneurons were marginally affected in the sub-regions of hippocampus (Fig. 3a,b). We next checked whether 
the loss of PLCγ1 had a differential effect on the numbers of a specific subtype of GABAergic neurons in the 
hippocampus. Double-immunostaining with antibodies to PV and SST revealed that the number of PV- and 
EYFP-double positive neurons was comparable between control and Plcg1F/F; Dlx5/6-Cre;EYFP mice across the 
hippocampal sub-regions (Fig. 3c,d). However, SST- and EYFP-double positive neurons were slightly decreased 
in each sub-region of hippocampus of Plcg1F/F; Dlx5/6-Cre;EYFP mice, although statistical significance was not 
reached in post-hoc test (Fig. 3c,e). We also examined the altered expression of GAD67, which is a major enzyme 
catalyzing the synthesis of GABA in most of inhibitory neurons. In parallel with the number of GABAergic neu-
rons, the expression of GAD67 was only slightly diminished throughout the sub-regions of hippocampus in aged 
Plcg1F/F; Dlx5/6-Cre mice (Fig. 3f,g).
At the local circuit level, GABAergic neuron exerts its diverse functions via inhibitory synapses. To assess 
any changes in the synaptic proteins of GABAergic neurons, we stained both VGAT (vesicular GABA trans-
porter) as a presynaptic marker and gephyrin as a postsynaptic marker for inhibitory synapses. The expression of 
VGAT was remarkably reduced, especially in DG and CA3 of the hippocampus in aged Plcg1F/F; Dlx5/6-Cre mice, 
whereas the immunoreactivity of gephyrin was similar between the genotypes across the hippocampal subregions 
(Fig. 3h–j). We further quantified the number of inhibitory synapses by counting the synaptic puncta co-localized 
with VGAT and gephyrin. GABAergic synaptic puncta were also considerably decreased in the hippocampus of 
Plcg1F/F; Dlx5/6-Cre mice, mainly in DG (P < 0.05 in post-hoc test) and CA3 region (P = 0.0538 in post-hoc test) 
(Fig. 3k). These results clearly indicate that the genetic deletion of PLCγ1 only marginally affect the number of 
GABAergic interneurons and possibly GABA synthesis in the hippocampus, while inhibitory synaptic puncta as 
well as presynaptic proteins in GABAergic synapses are markedly diminished in aged Plcg1F/F; Dlx5/6-Cre mice.
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Hippocampal inhibitory synaptic transmission is attenuated in the CA3 of aged Plcg1F/F; 
Dlx5/6-Cre mice. The reductions of inhibitory presynaptic protein and synaptic puncta may point to a func-
tional compromise at hippocampal synapses in aged Plcg1F/F; Dlx5/6-Cre mice. It is important to note, however, 
that molecular and structural changes at synapses do not necessarily involve functional changes. With the above 
immunohistochemical data in mind, we then sought to find a functional consequence of the changes in the 
number of inhibitory synapses in the hippocampus of aged Plcg1F/F; Dlx5/6-Cre mice. To pinpoint the functional 
aberrations in the hippocampus, we conducted the whole cell patch-clamp recording and recorded the spontane-
ous miniature excitatory postsynaptic currents (mEPSCs) and the spontaneous miniature inhibitory postsynaptic 
currents (mIPSCs) from pyramidal neurons in CA1 and CA3 regions. We found that spontaneous excitatory 
synaptic transmission were comparable between control and Plcg1F/F; Dlx5/6-Cre mice in CA1 pyramidal neu-
rons, exhibiting no difference in the amplitude and frequency of mEPSCs (Fig. 4a–c). In addition, there was no 
difference in the amplitude and frequency of mIPSCs in CA1 region, either (Fig. 4d–f). Importantly, however, 
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Figure 2. Aged Plcg1F/F; Dlx5/6-Cre mice show epileptic EEG patterns. (a) Schematic diagram of the EEG 
experimental procedure. (b) Representative recording traces of normal EEG patterns in control mice (left, 
30 s) and temporal expansion of the same recording trace in dotted square (right, 6 s). (c) Representative traces 
of abnormal EEG patterns in freely moving Plcg1F/F; Dlx5/6-Cre mice without handling stimulus (left, 30 s) 
and temporal expansion of the same recording trace in dotted square (right, 6 s). (d) Typical epileptic EEG 
activity in Plcg1F/F; Dlx5/6-Cre mice (left, 5 min) and temporal expansion of the same recording trace in dotted 
square (right, 6 s). (e) EEG band power during awake state for 1 hour in non-behavioral seizure epochs without 
handling stimulus (control, n = 4; Plcg1F/F; Dlx5/6-Cre, n = 6; two-way repeated measures ANOVA, genotype 
effect, *P = 0.0169, **P = 0.0054 in Sidak’s multiple comparison test). All data were expressed as mean ± SEM.
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Figure 3. Expression of GABAergic molecules and inhibitory synaptic puncta are markedly decreased in 
aged Plcg1F/F; Dlx5/6-Cre mice. (a) Representative confocal images of EYFP positive cells in the hippocampus. 
Scale bar: 500 μm. (b) Quantification of the number of GABAergic neurons in the hippocampus (control, 
n = 34 slices from 6 mice; Plcg1F/F; Dlx5/6-Cre, n = 36 slices from 6 mice; two-way repeated measures ANOVA, 
genotype effect, *P = 0.0181). (c) Representative confocal images of PV and SST expressing neurons co-
localized with EYFP in hippocampal subregions. Red arrowhead: co-localization of PV and EYFP. White 
arrowhead: co-localization of SST and EYFP. Scale bar: 100 μm. (d) Co-localization of PV and EYFP positive 
cells (n = 18 slices from 3 mice per genotype; two-way repeated measures ANOVA, genotype effect, P > 0.05). 
(e) Co-localization of SST and EYFP positive cells in the hippocampus (n = 18 slices from 3 mice per genotype; 
two-way repeated measures ANOVA, genotype effect, **P = 0.0081). (f) Representative confocal images of 
GAD67 expression in the hippocampus. Scale bar: 200 μm. (g) Quantification of the intensity of GAD67 in 
the hippocampus (control, n = 5 slices from 4 mice; Plcg1F/F; Dlx5/6-Cre, n = 6 slices from 3 mice; two-way 
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the frequency of mIPSCs in CA3 region was significantly decreased in aged Plcg1F/F; Dlx5/6-Cre mice compared 
to control mice without any change in the amplitude (Fig. 4j–l). On the other hand, both the amplitude and 
frequency of mEPSCs were normal in CA3 pyramidal neurons of Plcg1F/F; Dlx5/6-Cre mice, suggesting that func-
tional change in synaptic transmission is specific to inhibitory synapses in CA3 region (Fig. 4g–i). The reduction 
of mIPSCs frequency in CA3 region indicates either a decrease in release probability or inhibitory synapse loss. 
We next counted the number of GABAergic synaptic puncta at each layer from CA3 region to gauge layer-specific 
alterations of inhibitory synaptic puncta in Plcg1F/F; Dlx5/6-Cre mice. We discovered that GABAergic synaptic 
puncta were primarily reduced in stratum pyramidale (s.p.) and stratum oriens (s.o.) in CA3 of aged Plcg1F/F; 
Dlx5/6-Cre mice, whereas the number of GABAergic synaptic puncta in stratum lucidum (s.l.) and stratum radia-
tum (s.r.) was comparable between control and Plcg1F/F; Dlx5/6-Cre mice (Fig. S4a,b). These results demonstrate 
that both somatic inhibitory synapses at stratum pyramidale and dendritic inhibitory synapses at stratum oriens 
where basal dendrites of CA3 pyramidal neurons are located are selectively reduced in Plcg1F/F; Dlx5/6-Cre mice.
To verify whether this attenuation of synaptic inhibition in Plcg1F/F; Dlx5/6-Cre mice is age-dependent, we 
performed the same whole cell patch-clamp recording from hippocampal CA1 and CA3 regions in young adult 
(8 weeks old) Plcg1F/F; Dlx5/6-Cre mice. Most of measurements from mEPSC and mIPSC recordings were similar 
between the genotypes (Fig. S5). Interestingly, however, young Plcg1F/F; Dlx5/6-Cre mice showed increased ampli-
tude of mIPSC only in CA1 region compared with control mice, indicating that genetic deletion of PLCγ1 may 
cause distinct effects on hippocampal GABAergic neurons with age-dependent manner (Fig. S5d,e). Considering 
our immunohistochemical findings described above, these results demonstrate that the defect of PLCγ1 signaling 
in GABAergic interneurons could attenuate inhibitory synaptic transmission via selective GABAergic synapse 
loss in the CA3 region of hippocampus in aged Plcg1F/F; Dlx5/6-Cre mice.
Discussion
PLCγ1 is a crucial signal transducer and involved in various neuronal functions. However, the detailed molecular 
and cellular functions of PLCγ1 in vivo has not been fully understood in the brain. Several studies have indirectly 
proposed the plausible role of PLCγ1 in GABAergic neuron. TrkB signaling, the upstream pathway of PLCγ1, is 
reported to regulate the survival of newborn GABAergic neurons in the striatum23. In addition, the gene expres-
sion of GAD 65, a GABA-synthesizing enzyme localized at axon terminals, involves CREB-dependent BDNF/
TrkB signaling in cortical neurons24. As GABAergic neurons play essential roles in shaping excitatory synaptic 
information and regulating neuronal activity across the brain, it is very likely that PLCγ1 in GABAergic neurons 
may be also implicated in the regulation of GABAergic inhibition in the brain. In this study, we aim to determine 
the cell-type specific roles of PLCγ1 on neural functions, especially focusing on GABAergic neurons. To achieve 
this goal and identify the function of PLCγ1 in vivo, we generated the GABAergic neuron-specific PLCγ1 knock-
out mice by crossing Dlx5/6-Cre mice with the mice harboring the floxed-PLCγ1 allele. Most notably, routine 
handling stimulus to these mice led to the recurrent seizures in an age-dependent manner, which were accom-
panied by epileptic EEG signals and elevated gamma frequency band. Previously, we have studied other PLCγ1 
conditional knockout mice including Plcg1F/F; Nestin-Cre (Neuronal cell-specific) and Plcg1F/F; CaMKIIα-Cre 
(excitatory neuron-specific). None of these mice exhibited any signs of handling-induced seizures, demon-
strating that selective loss of PLCγ1 in GABAergic neurons is specifically related to the generation of seizures. 
Interestingly, the small number of aged control mice also showed mild signs of seizure at 10–11 months of age. 
It is unclear what may account for this observation, but this mild seizure from old control mice might be caused 
by aging as aging itself is associated with increased susceptibility for some types of seizure in rodents including 
C57BL6 mice25–27. Furthermore, frequent and continuous handling we used to induce seizure at daytime might 
be stressful to mice, leading to stress-induced seizure in some of aged control mice28,29.
In addition to handling-induced seizures, other anomalous behaviors were observed in aged Plcg1F/F; 
Dlx5/6-Cre mice. They displayed hypo-locomotion, reduced anxiety, and the deficit in contextual fear mem-
ory. Among these changes, reduced anxiety and attenuated freezing behavior differ from the typical phenotypes 
of epileptic mice mostly exhibiting heightened anxiety and increased freezing, implicating that aged Plcg1F/F; 
Dlx5/6-Cre mice are different from common epileptic mouse models30,31. In general, anxiety and contextual fear 
memory are linked to the functions of hippocampus and GABAergic dysfunction in the hippocampus could 
result in comparable behavioral phenotypes from other mouse models32–35. However, these concomitant behav-
ioral alterations in Plcg1F/F; Dlx5/6-Cre mice may be caused by structural and functional changes from multi-
ple brain regions because genetic deletion of PLCγ1 is not limited to the hippocampus. In a similar vein, the 
hypo-locomotion of Plcg1F/F; Dlx5/6-Cre mice could be explained by GABAergic dysfunction in the striatum, 
of which the principal neurons are GABAergic and mediate locomotive behaviors. Thus, the defects in the hip-
pocampus and other brain regions rendered by GABAergic neuron-specific loss of PLCγ1 may account for the 
alterations in anxiety level and contextual fear memory.
repeated measures ANOVA, genotype effect, **P = 0.0045). (h) Representative confocal images of VGAT and 
gephyrin immunoreactivity in each sub-region of hippocampus. Scale bar: 50 μm. (i, j) Quantification of VGAT 
and gephyrin immunoreactivity (control, n = 28 slices from 6 mice; Plcg1F/F; Dlx5/6-Cre, n = 20 slices from 6 
mice; VGAT, two-way ANOVA, genotype effect, ****PVGAT < 0.0001, **PDG = 0.0037, **PCA3 = 0.0027 by post-
hoc test; gephyrin, two-way ANOVA, genotype effect, P > 0.05). (k) Normalized inhibitory synaptic puncta 
quantified by the co-localization of VGAT and gephyrin (control, n = 28 slices from 6 mice; Plcg1F/F; Dlx5/6-Cre, 
n = 24 slices from 6 mice; two-way ANOVA, genotype effect, ****P < 0.0001, *P = 0.0260 in DG by post-hoc 
test). All data were expressed as mean ± SEM.
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Figure 4. Inhibitory synaptic transmission in hippocampal CA3 region is reduced in aged Plcg1F/F; Dlx5/6-
Cre mice. (a) Representative recording trace of mEPSCs recorded from hippocampal CA1 region in control 
and Plcg1F/F; Dlx5/6-Cre mice (control, n = 12, Plcg1F/F; Dlx5/6-Cre, n = 9). (b,c) Quantification of mEPSCs 
amplitude (b) and frequency (c) in CA1. (d) Representative recording trace of mIPSCs recorded from 
hippocampal CA1 region in control and Plcg1F/F; Dlx5/6-Cre mice (control, n = 10, Plcg1F/F; Dlx5/6-Cre, 
n = 12). (e,f) Quantification of mIPSCs amplitude (e) and frequency (f) in CA1. (g) Representative recording 
trace of mEPSCs recorded from hippocampal CA3 region in control and Plcg1F/F; Dlx5/6-Cre mice (control, 
n = 8, Plcg1F/F; Dlx5/6-Cre, n = 6). (h, i) Quantification of mEPSCs amplitude (h) and frequency (i) in CA3. 
(j) Representative recording trace of mIPSCs recorded from hippocampal CA3 region in control and Plcg1F/F; 
Dlx5/6-Cre mice (control, n = 6, Plcg1F/F; Dlx5/6-Cre, n = 9). (k,l) Quantification of mIPSCs amplitude (k) and 
frequency (l) in CA3 (frequency, unpaired t-test, *P = 0.0379). All data were expressed as mean ± SEM.
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At the cellular level, the total number of hippocampal GABAergic interneurons and expression of GAD67 were 
only marginally decreased in aged Plcg1F/F; Dlx5/6-Cre mice. In addition, SST-positive interneurons were slightly 
diminished across DG-CA3-CA1 regions, while there was no change in the number of PV-positive interneurons 
in the hippocampus of Plcg1F/F; Dlx5/6-Cre mice. Given that sub-regional patterns of reductions between total 
GABAergic neurons and SST-positive neurons in Plcg1F/F; Dlx5/6-Cre mice are analogous in the hippocampus, 
marginal decline in hippocampal GABAergic neuron by the deletion of Plcg1 could stem mostly from the loss 
of SST-positive neurons. Meanwhile, the expression of inhibitory presynaptic molecule, VGAT, was significantly 
attenuated in Plcg1F/F; Dlx5/6-Cre mice, primarily in DG and CA3 regions of hippocampus. Interestingly, the 
expression pattern of an inhibitory postsynaptic molecule, gephyrin, was similar between control and Plcg1F/F; 
Dlx5/6-Cre mice. Most importantly, the number of GABAergic synaptic puncta was considerably reduced in the 
hippocampus by the cell type-specific deletion of PLCγ1. Although not studied well in humans, low expression 
level of VGAT is associated with experimental animal models of epilepsy36–38. As hippocampus plays a central role 
in the generation of epileptic seizures, the loss of PLCγ1, especially in hippocampal GABAergic neurons, might 
cause the attenuation of GABAergic inhibition at hippocampal synapses.
Strengthening this idea, aged Plcg1F/F; Dlx5/6-Cre mice exhibited epileptic EEG abnormalities in vivo includ-
ing high frequency waveforms. At synaptic level, our electrophysiological results from acute brain slices con-
firmed that inhibitory synaptic transmission was markedly compromised especially at CA3 of the hippocampus. 
Analysis of high-magnification images from distinct hippocampal layers at CA3 further demonstrated that 
GABAergic synaptic puncta was especially decreased in stratum pyramidale and stratum oriens in aged Plcg1F/F; 
Dlx5/6-Cre mice. From these findings, it seems reasonable to think that impaired synaptic inhibition measured 
by mIPSC at CA3 in Plcg1F/F; Dlx5/6-Cre mice could be due to the reduction of GABAergic synapses at both 
somatic and dendritic sites. It is important to note that, unlike aged mice, the amplitude of mIPSC at CA1 was 
increased by the genetic deletion of Plcg1 in young adult Plcg1F/F; Dlx5/6-Cre mice. This finding suggests that 
PLCγ1 might have temporally distinct roles in regulating GABA-mediated synaptic inhibition in the hippocam-
pus with age-dependent manner. In young animal, irrespective of the possible role of PLCγ1 in epileptogenesis, 
PLCγ1 might be involved in regulating the expression of inhibitory postsynaptic molecules such as gephyrin and 
GABAA receptor. Together, our results highlight an essential role of PLCγ1 in maintaining normal GABAergic 
neuronal functions in the hippocampus. Moreover, the dysfunction of PLCγ1 may cause deficits in inhibitory 
synaptic transmission and raise the susceptibility of seizure in aged mice, potentially leading to behavioral seizure 
by handling-stimulus.
Some unanswered questions remain in our study. First, it is intriguing to speculate why the handling-induced 
seizures in Plcg1F/F; Dlx5/6-Cre mice show age-related onset. Behavioral seizure in Plcg1F/F; Dlx5/6-Cre mice 
occurred over 6 months of age up to 14 months old. This age range is approximately comparable to 38–47 years 
old of middle-aged human. Late-onset seizures can be caused by complex factors such as brain damage, infection, 
aging, and environment, whereas specific molecular mechanisms underlying this seizure generation is mostly 
unclear39,40. Recently, a couple of papers have described the late-onset seizures in several genetic KO mice41,42, 
yet linkage between PLCγ1 and these genes remains unexplored. Previous studies suggest that GABA-mediated 
inhibition can become compromised with ageing. Loss of GABAergic neurons, weakened synthesis of GABA, and 
impaired inhibitory synaptic transmission were all observed in aged rodents and humans43–48. Besides, seizure 
susceptibility to hippocampal CA3 kindling was elevated in aged mice26. Although we have no satisfactory expla-
nation for adult onset seizure, it is possible that malfunction of GABAergic neurons caused by the lack of PLCγ1 
could not induce the critical defects in the developmental and early postnatal stages, but as Plcg1F/F; Dlx5/6-Cre 
mice get older, the damages given to GABAergic neurons would be accelerated and gradually accumulated in 
hippocampal circuit. When these accumulated damages reach a certain threshold, it might result in the attenua-
tion of synaptic inhibition through reduced GABAergic tone in the hippocampus in middle age and more elderly 
brain49.
Second, the detailed molecular mechanisms causally linking PLCγ1 to GABAergic neurons and epileptogene-
sis are not yet clear. Previously, several studies have focused on the role of PLCγ1 for epileptogenesis in excitatory 
neurons. In temporal lobe epilepsy model, hyperexcitation of excitatory neurons were induced by chemoconvul-
sants such as pilocarpine and kainic acid that activate muscarinic acetylcholine receptors and the glutamatergic 
receptors respectively50. This abnormal hyperexcitation of neurons caused the activation of cellular signaling 
pathways, including the elevated phosphorylation of PLCγ112,14. Indeed, we found that excitatory neuron-specific 
deletion of PLCγ1 lowered the susceptibility for pilocarpine-induced seizure in Plcg1F/F; CaMKIIα-Cre mice. 
Converging lines of evidence suggest that BDNF/TrkB signaling is a major candidate pathway of epileptogen-
esis, which is the upstream of PLCγ1. Most of these studies focused on the cellular functions of BDNF/TrkB 
signaling in excitatory neurons. For instance, BDNF level and activation of TrkB in hippocampal excitatory neu-
rons were increased in animal models of epilepsy and human patients6,8,51,52. However, BDNF signaling can also 
affect GABA-mediated inhibition via inhibitory synapses. It has been documented that the treatment of BDNF 
facilitates gephyrin clustering that stabilizes glycine and GABAA receptors at inhibitory synapse53. In line with 
this report, BDNF also augments the transcription of GABAA receptor subunit and expression of gephyrin54. 
Furthermore, PLC-dependent BDNF/TrkB pathway can exert temporally differential modulation on GABAA 
receptor-mediated transmission in excitatory neurons55. As with our electrophysiological data, it is plausible that 
BDNF/TrkB signaling, potentially via PLCγ1, can have distinct and opposite roles in regulating GABA-mediated 
inhibition and epileptogenesis with age-dependent manner. Yet the possible involvement of BDNF/TrkB signaling 
in coordinating GABAergic neuronal functions and epileptogenesis is still elusive56,57.
Another candidate pathway mediating PLCγ1 signaling is a neuregulin 1 (NRG1) and its receptor 
ErbB4-related signaling pathway. Neuregulin 1, first identified as a schizophrenia risk gene, is a trophic factor 
containing EGF (epidermal growth factor)-like domain. This protein has been shown to function primarily in 
neural development and synapse formation. Of particular note is the fact that ErbB family is a tyrosine receptor 
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kinase that can also recruit PLCγ1-related signaling. Dysfunction of this NRG1/ErbB4 signaling in GABAergic 
neurons has been reported to induce epilepsy and psychiatric disorders in human where single nucleotide poly-
morphisms of these proteins were closely linked to E/I imbalance58–60. Although the exact molecular mechanisms 
behind the defective GABAergic functions remain open questions, it is very likely that PLCγ1 might function 
as a convergence point from various receptor tyrosine kinases and the specific signaling pathway working on 
GABAergic neurons could regulate the appropriate GABAergic inhibition via the activation of PLCγ1.
In the current work, we uncovered the physiological role of PLCγ1 in GABAergic neuron in vivo by utilizing 
Plcg1F/F; Dlx5/6-Cre mice. Our findings suggest that PLCγ1 may be one of principal molecular players in regu-
lating GABA-mediated synaptic inhibition, especially in hippocampal GABAergic neurons, whose dysfunction 
may result in epileptogenesis in aged mice. As the research about age-related neurological disorders becomes 
more and more important than ever before, our study will offer a new perspective on the cell-type specific molec-
ular mechanisms of epileptogenesis in middle-to-old age. Undoubtedly, future studies will further examine the 
detailed molecular mechanism via which PLCγ1 exerts its effects on GABAergic neurons.
Methods
Animals. Plcg1F/F mice (C57BL/6J background) were generated as previously described61. To generate 
GABAergic neuron-specific PLCγ1 knockout mice, Dlx5/6-Cre mice (Jax mouse cat No.008199) were crossed 
with Plcg1F/F mice to produce Plcg1F/F; Dlx5/6-Cre mice. Plcg1F/F littermate mice were used as controls in most 
of experiments except EYFP immunohistochemistry (Fig. 3a–e). To label PLCγ1-deficient GABAergic neurons, 
we crossed R26R-EYFP mice (Jax mouse cat No.006148) with Plcg1F/F; Dlx5/6-Cre mice and generated Plcg1F/F; 
Dlx5/6-Cre;EYFP mice. Dlx5/6-Cre;EYFP mice were used as controls in Fig. 3a–e. For the genetic deletion of 
PLCγ1 in excitatory neurons, CaMKIIα-Cre (MGI ID: 2176753) mice were bred to Plcg1F/F mice to generate 
Plcg1F/F; CaMKIIα-Cre mice. Mice were maintained under standard housing conditions on a 12-hour light/dark 
cycle. Food and water were available ad libitum. All animal experiments were conducted according to proto-
cols approved by Institutional Animal Care and Utilization Committee of Ulsan National Institute of Science 
and Technology. In our study, 10–16 months old mice (aged control and Plcg1F/F; Dlx5/6-Cre mice, male and 
female) were used throughout the behavioral tests (Fig. 1), in vivo EEG recording (Fig. 2), immunohistochem-
istry (Fig. 3), and in vitro brain slice electrophysiology experiment (Fig. 4). Young adult mice (8–12 weeks old, 
male and female) were also utilized for western blotting, fluorescence in situ hybridization, pilocarpine-induced 
seizure, additional locomotion and anxiety tests. The experimenter was not blind to the genotypes of animals.
Tissue preparation and immunohistochemistry. Aged mice (10–16 months old) were deeply anaesthe-
tized with avertin (250 mg/kg) and perfused transcardially with cold phosphate buffered saline followed by cold 
4% paraformaldehyde. The dissected brains were fixed in 4% PFA at 4 °C overnight and then serially sectioned 
(40 μm) using a vibratome. Free-floating sections were permeabilized in 0.2% Triton X-100 in PBS for 1 hour and 
blocked in PBST containing 10% normal goat serum for 1 hour at room temperature. Sections were incubated in 
primary antibody solution diluted in PBST containing 10% NGS for overnight at 4 °C. Following three washes 
in PBS, sections were incubated with Alexa Fluor-tagged secondary antibodies at 1:400 dilution for 2 hours at 
room temperature. Primary antibodies used in this study were anti-Parvalbumin (Synaptic systems, 195 004, 
1:1000), anti-Somatostatin (Santa cruz, sc-7819, 1:500), anti-GAD67 (Millipore, MAB5406, 1:200), anti-Gephyrin 
(Synaptic systems, 147 111, 1:200), anti-VGAT (Synaptic systems, 131 003, 1:200), anti-GFP (CiteAb, GFP-1010, 
1:1000), and anti-NeuN (Sigma, MAB377, 1:1000). Secondary antibodies were Alexa Fluor 488 or Alexa Fluor 
594 or Alexa Fluor 647-conjugated anti-rabbit, anti-mouse, anti-chicken, anti-guinea pig (Invitrogen, 1:400). All 
sections were counterstained with Hoechst 33258 (Sigma, 94403, 1:1000).
Image acquisition and quantitative analysis. Images were derived from FV1000 confocal laser scan-
ning microscope (Olympus) using UPLSAPO 10X NA:0.40, UPLSAPO 40 × 2 NA:0.95, UPLSAPO 60X O 
NA:1.35 objective lens and Axio zoom microscope (Carl Zeiss). Images were analyzed by ImageJ (NIH) pro-
gram. Identical acquisition parameters were used for all the brain slices within a single set of experiment. Image 
analysis was not performed blind to the genotypes of animals. Inhibitory synapse was defined as co-localization 
between inhibitory presynaptic marker (VGAT) and inhibitory postsynaptic marker (Gephyrin). Puncta analyzer 
ver2.0 plugin for ImageJ was downloaded from github (https://github.com/physion/puncta-analyzer) and used to 
quantify the inhibitory synaptic puncta. The protocol using the Puncta analyzer is well described in the previous 
article62.
Fluorescence in situ hybridization. Fluorescence in situ hybridization was conducted as previously 
described63. Frozen brain sections (14 μm thick) from young adult mice (8–12 weeks old) were cut coronally 
through the cortex and striatum formation. Sections were thaw-mounted onto Superfrost Plus Microscope Slides 
(Fisher Scientific #12-550-15). The sections were fixed in 4% paraformaldehyde for 10 min, dehydrated in increas-
ing concentrations of ethanol for 5 min, and finally air-dried. Tissues were then pretreated for protease digestion 
for 10 min at room temperature. Probe hybridization and amplification were performed at 40 °C using HybEZ 
hybridization oven (Advanced Cell Diagnostics, Hayward, CA). The probes used in this study were three syn-
thetic oligonucleotides complementary to the nucleotide (nt) sequence 1116–2000 of Mm-Plcg1-C2, nt 62–3113 
of Mm-Gad1-C2, and nt 464–1415 of Mm-Slc17a7/Vglut1-C3 (Advanced Cell Diagnostics, Hayward, CA). The 
labeled probes were conjugated to Alexa Fluor 488, Atto 550, and Atto 647. The sections were hybridized with the 
labeled probe mixture at 40 °C for 2 hours per slide. Unbound hybridization probes were removed by washing the 
sections three times with 1x wash buffer at room temperature for 2 min. Following steps for signal amplification 
included incubations at 40 °C with Amplifier 1-FL for 30 min, with Amplifier 2-FL for 15 min, with Amplifier 
3-FL for 30 min, and with Amplifier 4 Alt B-FL for 15 min. Each amplifier solution was removed by washing with 
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1x wash buffer at room temperature for 2 min. The slides were viewed, analyzed, and photographed using TCS 
SP8 Dichroic/CS (Leica).
Western blot. Proteins were extracted from brain tissue of young adult mice (8 weeks old) using lysis buffer 
containing 1% Triton X-100, 10% glycerol, 150 mM NaCl, 50 mM HEPES, 2.5 mM sodium pyrophosphate (diba-
sic), 1 mM EGTA, 1 mM EDTA. Protease and phosphatase inhibitors including NaF, Aprotinin, Na3VO4, phen-
ylmethylsulfonyl fluoride, Leupeptin, and pepstatin A were also freshly added. Bovine serum albumin was used 
to measure protein concentration by Bradford assay (BIO-RAD, 5000006). Proteins with sample buffer were 
denatured at 95 °C for 5 min. The same volume of samples was loaded in the gel, electrophoresed, and transferred 
into nitrocellulose membrane. Membranes were blocked by 5% skim milk in TTBS and incubated in primary 
antibodies at 4 °C for overnight. Primary antibodies used for western blotting were β-actin (GeneTex, 1:5000) 
and PLCγ1 (generated in lab64, 1:3000). Membranes were washed three times, each for 10 min and then incubated 
with secondary HRP-conjugated antibodies (VWR, 1:5000) for 1 hour at room temperature. After washing, ECL 
(GE Healthcare, RPN2235) was used to detect the protein band signal through ChemiDocTM (BIO-RAD). ImageJ 
was used for the quantification of protein bands.
Electroencephalographic (EEG) recordings. Aged Plcg1F/F and Plcg1F/F; Dlx5/6-Cre mice (10–14 months 
old) were used for EEG recordings. Mice were anesthetized with avertin (250 mg/kg) by intraperitoneal injec-
tion. Telemetry transmitter (TA10ETA-F20, ETA-F10) were implanted bilaterally through holes in the skull (AP 
−1.5 mm, ML ± 1.3 mm, directly on the dura mater overlying the hippocampus from each hemisphere) and cov-
ered with dental cement. After one week of recovery, EEG signal was monitored on freely moving mice using 
EEG recording system (Dataquest A.R.T, Data Sciences International). EEG data were acquired at a sampling rate 
of 500 Hz using DSI Dataquest A.R.T. system without a filter cutoff. Simultaneous long-term video could not be 
taken due to the limitation of equipment. Experimenter directly checked and monitored both behavioral seizure 
and EEG during daytime. To induce the seizure, mice were gently grabbed and handled once a day for a week. 
Electrographic EEG seizures were analyzed by using Neuroscore software (Data Sciences International).
Brain slice electrophysiology. Aged Plcg1F/F and Plcg1F/F; Dlx5/6-Cre mice (10–16 months old) were used 
for whole-cell patch clamp recording. After anesthetizing a mouse with halothane, the brain was isolated and 
the hippocampus was dissected. Hippocampal slices (300 μm thick) were prepared using a vibratome (Leica, 
VT1000S) in an ice-cold cutting solution containing (in mM) 234 sucrose, 2.5 KCl, 1.25 NaH2PO4, 24 NaHCO3, 
11 glucose, 0.5 CaCl2, 10 MgSO4, saturated with 95% O2 and 5% CO2. The slices were recovered at 35 °C for one 
hour and later maintained at room temperature in a recovery artificial cerebrospinal fluid solution containing (in 
mM) 124 NaCl, 3 KCl, 1.25 NaH2PO4, 26 NaHCO3, 10 glucose, 6.5 MgSO4, 1 CaCl2, saturated with 95% O2 and 
5% CO2. Following the recovery, the slice was transferred to a submerged recording chamber and continuously 
perfused with a recording aCSF solution containing (in mM) 124 NaCl, 3 KCl, 1.25 NaH2PO4, 26 NaHCO3, 10 
glucose, 1.3 MgSO4, 2.5 CaCl2, saturated with 95% O2 and 5% CO2 at room temperature throughout the exper-
iments. For miniature excitatory postsynaptic currents (mEPSCs), the recording aCSF was supplemented with 
1 μM TTX and 50 μM picrotoxin. Whole-cell recordings of CA1 and CA3 neurons were made using pipettes of 
3–7 MΩ resistance. The cells were held at −70 mV, and the internal solution contained (in mM) 125 CsMeSO3, 
2.8 NaCl, 20 HEPES, 0.4 EGTA, 4 ATP-Mg, 0.5 GTP-Na2, 10 phosphocreatine-Na2, 5 QX314 (pH = 7.25 and 
osmolality = 285–290 mOsm). For miniature inhibitory postsynaptic currents (mIPSCs), the recording aCSF was 
supplemented with 1 μM TTX, 10 μM DNQX and 50 μM D-AP5. Whole-cell recordings of CA1 and CA3 neu-
rons were made using pipettes of 3–7 MΩ resistance. The cells were held at −70 mV, and the internal solution 
contained (in mM) 134 CsCl, 2 MgCl2, 10 HEPES, 1 EGTA, 2 ATP-Mg, 0.5 GTP-Na2, 5 phosphocreatine-Na2 
(pH = 7.25 and osmolality = 285–290 mOsm). Data were collected with a MultiClamp 700B amplifier (Molecular 
Devices), digitized at 10 kHz with a Digidata 1550 digitizer (Molecular Devices). pClamp10 software (Molecular 
Devices) was used for data acquisition and analysis. mEPSCs and mIPSCs were analyzed with MiniAnalysis soft-
ware (Synaptosoft Inc) using a detection threshold of 8 pA.
For whole-cell patch clamp recording in young adult mice (8 weeks old), acute brain slices (300 μm) containing 
hippocampus were obtained from control and Plcg1F/F; Dlx5/6-Cre mice using tissue vibratome (VT1200S, Leica). 
After dissection, slices were recovered for 20 min at 34 °C and additional 40 min at room temperature in artificial 
cerebrospinal fluid (aCSF) containing 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 1 mM 
MgCl2, 2 mM CaCl2 and 15 mM glucose oxygenated with 95% O2 and 5% CO2 before recording. Whole-cell volt-
age clamp recordings were performed in the recording chamber perfused with aCSF containing 0.5 M TTX citrate 
and 25 μM D-AP5 at 30–31 °C. Recordings were made with glass pipettes (2.5–3.5 MΩ) filled with Cs+-based 
low Cl− internal solution containing 135 mM CsMeSO3, 10 mM HEPES, 1 mM EGTA, 3.3 mM QX-314 chloride, 
0.1 mM CaCl2, 4 mM Mg-ATP, 0.3 mM Na3-GTP, 8 mM Na2-phosphocreatine (pH 7.3 with CsOH). To obtain 
miniature postsynaptic currents in the same cell, membrane potential was first held at −70 mV (reversal potential 
of chloride, junction potential corrected) to measure miniature excitatory postsynaptic currents (mEPSCs) and 
then held at 0 mV (reversal potential of ionotropic glutamate receptors, junction potential corrected) to measure 
miniature inhibitory postsynaptic currents (mIPSCs). CA1 and CA3 neurons were identified by IR-DIC optics 
(Olympus BX51WI microscope). Voltage-clamp recording was performed using Multiclamp 700B (Molecular 
Devices) and signals were filtered at 2 kHz and digitized at 10 kHz. Recording data were monitored and acquired 
online by WinWCP (Strathclyde Electrophysiology Software). Clampfit 10.7 software (Molecular Devices) was 
used for data analysis offline. mEPSCs and mIPSCs were analyzed with Mini Analysis software (Synaptosoft Inc.) 
with the detection threshold 5 pA for mEPSCs and threshold 10 pA for mIPSCs.
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Seizure detection and assessment of seizure susceptibility by pilocarpine. To evoke and detect 
handling-induced behavioral seizures, mice (male and female) were gently handled by grasping the tail or scruff 
2–3 times a week throughout the lifetime of mice. Behavioral seizure was scored by using Racine scale17. In 
pilocarpine-induced seizure experiment, young adult mice (8–12 weeks old) were first injected with N-methyl 
scopolamine bromide (1 mg/kg, Sigma S8502) before the injection of pilocarpine to inhibit the peripheral cholin-
ergic effects. 15 minutes later, mice were treated with pilocarpine (300 mg/kg, Sigma P6503). After administration 
of pilocarpine, behavioral seizure score was measured using modified Racine scale for 2 hours: grade (1) stiffness 
and rigid posture; (2) head nodding; (3) partial forelimb clonus; (4) severe whole body continuous seizures; (5) 
falling, forelimb clonus and jumping (generalized motor convulsions). To cease the epileptic activity, diazepam 
(5 mg/kg, Dongwha pharm) was injected to mice. Mortality was comparable during pilocarpine-induced seizure 
between the genotypes in young adult mice.
Behavior test. Behavior test was conducted at daytime (10:00 A.M–14:00 P.M) under dim light condition. 
Male mice were used in behavioral experiments and the ages of the mice are as follows: aged adult mice (10–16 
months) for open field test, elevated plus maze, Y maze, contextual fear conditioning, tail suspension test, and 
forced swim test (Fig. 1); young adult mice (8–12 weeks) for open field test and elevated plus maze (Fig. S2). To 
minimize the effects of stress on behavioral outcome, we started with the least stressful test and continued to 
perform other tests in the following order: elevated plus maze, open field test, Y-maze, contextual fear condition-
ing, tail suspension test, forced swim test. After behavioral test, mice were used in other experiments including 
immunohistochemistry, EEG recording, and brain slice electrophysiology.
Open-field test. Open field test was performed in a square white chamber (length 45 cm × width 45 cm × height 
40 cm) under indirectly low illumination. Mice were gently placed in center region (20 cm × 20 cm) and allowed 
to freely explore for 60 min. The movements were recorded and analyzed by SMART video tracking system 
(Panlab).
Elevated plus maze. The elevated plus maze consisted of four arms, elevated 50 cm above the floor. Two arms 
were enclosed by 15 cm height walls, whereas two arms were open without walls. Mice were gently placed in 
center region and allowed to freely explore for 10 min. Overall activity was recorded and analyzed by SMART 
video tracking system.
Y maze. The white acryl maze consisted of three arms (length 35 cm × width 4 cm × height 15 cm). Three arms 
were extended from center region at equally 120° angle. In indirect, low lighting, mice were placed into center 
region and allowed to freely move through maze for 10 min. The spontaneous alternation was calculated with the 
following equation: The spontaneous alternation (%) = [(number of spontaneous alternations)/(total number of 
arm entries - 2)] × 100.
Contextual fear conditioning. Contextual fear conditioning was conducted in fear conditioning chamber 
(Panlab, Barcelona, Spain). In training session, mice were allowed to freely explore conditioning chamber for 
2 min. After 2 min, sound pulse (amplitude 1, frequency 400 Hz) was given for 30 seconds and 0.8 mA electric 
footshock was delivered for 2 sec. After 24 hours, mice were put in the same conditioning chamber to test con-
textual fear memory for 3 min. The freezing time was recorded and analyzed by software (Panlab, Freezing 2.0 
version).
Tail suspension test. Mice were suspended by adhesive taping their tail to suspension apparatus (length 
50 cm × width 15 cm × height 30 cm, Harvard). The immobility time was recorded for 6 min, analyzed by SMART 
video tracking system, and manually counted by experimenter.
Forced swim test. The apparatus was a glass cylinder filled with water (25 °C, 20 cm diameter, 30 cm height). 
Mice were placed into cylinder and swimming behavior was recorded by SMART video tracking system for 6 min. 
The immobility time in last 4 min was scored manually.
Statistics. We performed all statistical analyses using GraphPad Prism software (version 7, GraphPad 
Software). The appropriate statistical methods for each experiment were described in the figure legend and 
Supplementary Table. Summary graphs were all shown as mean ± SEM. Chi-square test, unpaired student t-test, 
two-way ANOVA with post-hoc Sidak’s multiple comparison test, two-way repeated measures ANOVA with 
post-hoc Sidak’s multiple comparison test were used to determine statistical differences between the genotypes. 
P value (<0.05) was considered as statistically significant. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. 
The details of statistical analysis were presented in the Supplementary Table.
Data availability
The datasets produced during the current study are available from the corresponding author on request.
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